Digital Therapeutics (DTx) Expand Multimodal Treatment Options for Chronic Low Back Pain: The Nexus of Precision Medicine, Patient Education, and Public Health.
Autor: | Rohaj, Aarushi, Bulaj, Grzegorz |
---|---|
Předmět: |
CHRONIC pain treatment
LUMBAR pain THERAPEUTICS COMPUTERS in medicine ANTIDEPRESSANTS DIGITAL technology MOBILE apps VIRTUAL reality HOME care services BREATHING exercises NONSTEROIDAL anti-inflammatory agents PHYSICAL therapy INDIVIDUALIZED medicine PUBLIC health SELF-consciousness (Awareness) SELF-efficacy COMBINED modality therapy PATIENT education INTEGRATED health care delivery RELAXATION techniques OPIOID analgesics ALTERNATIVE medicine PAIN management COGNITIVE therapy |
Zdroj: | Healthcare (2227-9032); May2023, Vol. 11 Issue 10, p1469, 18p |
Abstrakt: | Digital therapeutics (DTx, software as a medical device) provide personalized treatments for chronic diseases and expand precision medicine beyond pharmacogenomics-based pharmacotherapies. In this perspective article, we describe how DTx for chronic low back pain (CLBP) can be integrated with pharmaceutical drugs (e.g., NSAIDs, opioids), physical therapy (PT), cognitive behavioral therapy (CBT), and patient empowerment. An example of an FDA-authorized DTx for CLBP is RelieVRx, a prescription virtual reality (VR) app that reduces pain severity as an adjunct treatment for moderate to severe low back pain. RelieVRx is an immersive VR system that delivers at-home pain management modalities, including relaxation, self-awareness, pain distraction, guided breathing, and patient education. The mechanism of action of DTx is aligned with recommendations from the American College of Physicians to use non-pharmacological modalities as the first-line therapy for CLBP. Herein, we discuss how DTx can provide multimodal therapy options integrating conventional treatments with exposome-responsive, just-in-time adaptive interventions (JITAI). Given the flexibility of software-based therapies to accommodate diverse digital content, we also suggest that music-induced analgesia can increase the clinical effectiveness of digital interventions for chronic pain. DTx offers opportunities to simultaneously address the chronic pain crisis and opioid epidemic while supporting patients and healthcare providers to improve therapy outcomes. [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |